Cargando…
Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis
Colorectal cancer (CRC) is the second leading cause of cancer deaths worldwide. Stage IV CRC patients have poor prognosis with a five-year survival rate of 14%. Liver metastasis is the main cause of mortality in CRC patients. Since current screening tests have several drawbacks, effective stable non...
Autores principales: | Nassar, Farah J., Msheik, Zahraa S., Itani, Maha M., Helou, Remie El, Hadla, Ruba, Kreidieh, Firas, Bejjany, Rachelle, Mukherji, Deborah, Shamseddine, Ali, Nasr, Rihab R., Temraz, Sally N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921943/ https://www.ncbi.nlm.nih.gov/pubmed/33669508 http://dx.doi.org/10.3390/diagnostics11020341 |
Ejemplares similares
-
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
por: Temraz, Sally, et al.
Publicado: (2021) -
Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications
por: El Halabi, Ibrahim, et al.
Publicado: (2018) -
Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study
por: Temraz, Sally, et al.
Publicado: (2023) -
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021) -
The Crosstalk between Microbiome and Immune Response in Gastric Cancer
por: Nasr, Rihab, et al.
Publicado: (2020)